Organogenesis Holdings Financial Overview
Organogenesis Holdings's market cap is currently $600.29M. The company's EPS TTM is $0.123; its P/E ratio is ―; Organogenesis Holdings is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $0.21. See an overview of income statement, balance sheet, and cash flow financials.
